Results 241 to 250 of about 87,303 (273)

The role of the 3'-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4⁺ T cells. [PDF]

Front Immunol
Yukselten Y, Wishah H, Wang L, Sutton RE.   +3 more
europepmc   +1 more source

Comprehensive bioinformatics analysis uncover molecular pathways shared between osteoarthritis and atherosclerosis. [PDF]

BMC Musculoskelet Disord
Jin Y, Zhang H.
europepmc   +1 more source

Advancing gene editing therapeutics: Clinical trials and innovative delivery systems across diverse diseases. [PDF]

Mol Ther Nucleic Acids
Raigani M, Eftekhari Z, Adeli A, Kazemi-Lomedasht F.   +3 more
europepmc   +1 more source

Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia. [PDF]

Cell Biosci
Chen Q, Li Y, Zhu Q, Li Z, Shao G, Liu Y, Jiang P, Tao Q, Shen L, Zhu J, Wei L, Li Y, Du X.   +12 more
europepmc   +1 more source

Controversial role of smallpox on historical positive selection at the CCR5 chemokine gene (CCR5-Δ32)

The Journal of Infection in Developing Countries, 2009
openaire   +5 more sources

Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies. [PDF]

Nat Commun
Feist WN, Luna SE, Ben-Efraim K, Filsinger Interrante MV, Amorin A, Johnston NM, Bruun TUJ, Utz A, Ghanim HY, Lesch BJ, McLaughlin TM, Dudek AM, Porteus MH.   +12 more
europepmc   +1 more source

Maraviroc enhances Bortezomib sensitivity in multiple myeloma by inhibiting M2 macrophage polarization via PI3K/AKT/RhoA signaling pathway in macrophages. [PDF]

Cell Div
Yang H, He Y, Qu F, Zhu J, Deng L, Jiang F, Wu X, Chen Y, Kashif A, Wang X.   +9 more
europepmc   +1 more source

From scRNA-seq to therapeutic targets: Unveiling the impact of activated mast cells on intestinal dysfunction in acute pancreatitis. [PDF]

World J Gastroenterol
Li B.
europepmc   +1 more source

Genetic signatures in the highly virulent subtype B human immunodeficiency virus-1 conferring resistance to broadly neutralizing antibodies. [PDF]

iScience
Honnayakanahalli Marichannegowda M, Agyekum G, Aparicio CZ, Heredia A, Wang Y, Song H.   +5 more
europepmc   +1 more source